Page last updated: 2024-08-17

medroxyprogesterone acetate and Anemia

medroxyprogesterone acetate has been researched along with Anemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Weisberg, E	1
Grimes, D	1
Ertan, K; Küçük, T	1
Aksu, F; Benian, A; Budak, E; Cepni, I; Madazli, R	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Anemia

Article	Year
Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers. Clinical and experimental obstetrics & gynecology, 2008, Volume: 35, Issue:1 Topics: Administration, Oral; Adult; Anemia; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Perimenopause; Prospective Studies; Smoking; Treatment Outcome	2008

Article

Year

Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers.

Clinical and experimental obstetrics & gynecology, 2008, Volume: 35, Issue:1

Topics: Administration, Oral; Adult; Anemia; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Perimenopause; Prospective Studies; Smoking; Treatment Outcome

2008

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Anemia

Article	Year
Contraceptive options for women in selected circumstances. Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5 Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult	2010
DMPA good choice for women with sickle cell. Network (Research Triangle Park, N.C.), 1999,Winter, Volume: 19, Issue:2 Topics: Africa; Africa South of the Sahara; Anemia; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developing Countries; Disease; Family Planning Services; Maternal Mortality; Medroxyprogesterone Acetate; Mortality; Population; Population Dynamics; Women	1999
High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents. The Australian & New Zealand journal of obstetrics & gynaecology, 1997, Volume: 37, Issue:2 Topics: Adolescent; Anemia; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Progesterone Congeners; Treatment Outcome	1997